34911-25-6

Basic information

• Product Name: 7-CHLORO-1-INDANONE
• Synonyms: 7-CHLORO-1-INDANONE;7-CHLORO-INDAN-1-ONE;7-chloro-2,3-dihydroinden-1-one;7-chloro-2,3-dihydro-1H-inden-1-one;REF DUPL: 7-Chloro-1-indanone;1H-Inden-1-one, 7-chloro-2,3-dihydro-
• CAS NO: 34911-25-6
• Molecular Formula: C₉H₇ClO
• Molecular Weight: 166.6
• Product Categories: Indane/Indanone and Derivatives
• Mol File: 34911-25-6.mol
• Article Data: 9

Chemical Properties

• Melting Point: 98 °C
• Boiling Point: 288.2 °C at 760 mmHg
• Flash Point: 129.3 °C
• Appearance: /
• Density: 1.312 g/cm³
• Vapor Pressure: 0.00237mmHg at 25°C
• Refractive Index: 1.6
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 7-CHLORO-1-INDANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-CHLORO-1-INDANONE(34911-25-6)
• EPA Substance Registry System: 7-CHLORO-1-INDANONE(34911-25-6)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 34911-25-6(Hazardous Substances Data)

Usage

Description

7-CHLORO-1-INDANONE is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique chemical structure, which includes a chlorine atom at the 7th position and an indanone moiety. 7-CHLORO-1-INDANONE is known for its potential applications in the development of therapeutic agents.

Uses

Used in Pharmaceutical Industry:
7-CHLORO-1-INDANONE is used as a reagent for the synthesis of tetracyclic quinoline and quinoxaline carboxamides. These compounds are known for their therapeutic properties as topoisomerase inhibitors, which play a significant role in the treatment of various diseases, particularly cancer.
In the synthesis process, 7-CHLORO-1-INDANONE serves as a key building block, providing the necessary structural framework for the formation of the final therapeutic agents. Its unique chemical properties allow for the creation of complex molecular structures with potential applications in medicine.
The use of 7-CHLORO-1-INDANONE in the pharmaceutical industry highlights its importance in the development of novel therapeutic agents. Its role in the synthesis of topoisomerase inhibitors demonstrates its potential in contributing to the fight against cancer and other diseases. As research continues, it is likely that new applications for this versatile compound will be discovered, further expanding its utility in the pharmaceutical field.

InChI:InChI=1/C9H7ClO/c10-7-3-1-2-6-4-5-8(11)9(6)7/h1-3H,4-5H2

Upstream product

• 408314-52-3 4-amino-7-chloro-indan-1-one 
• 112518-97-5 C₁₇H₁₅ClO₆ 
• 89638-23-3 1-(2-chlorophenyl)-2-propen-1-one 
• 7664-93-9 sulfuric acid 
• 1027979-10-7 3-Chlor-2'-propionaphthen 
• 628732-03-6 7-amino-2,3-dihydro-1H-inden-1-one 
• 58161-36-7 N-(3-oxo-2,3-dihydro-1H-inden-4-yl)acetamide 
• 32202-61-2 4-aminoindan 
• 77802-37-0 N-(2,3-dihydro-1H-inden-4-yl)acetamide 
• 609-65-4 o-chlorobenzoyl chloride 
• 118-91-2 ortho-chlorobenzoic acid 
• 91131-19-0 3-(dimethylamino)-1-(2-chlorophenyl)propan-1-one 
• 1829-60-3 dimethyl 7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate 
• 1885-76-3 2-cyano-3-nitrotoluene 

Relevant articles and documents

-

-

CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES

The present invention relates to a pharmaceutical composition for treating or preventing CNS disorders containing a carbamate derivative compound and/or pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or prevention CNS disorders comprising administering a carbamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of CNS disorders.

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.